The CLEVER Study - Coreg And Left Ventricular Mass Regression

PHASE3CompletedINTERVENTIONAL
Enrollment

287

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

August 31, 2008

Study Completion Date

August 31, 2008

Conditions
Hypertrophy, Left Ventricular
Interventions
DRUG

carvedilol MR

Study drug

DRUG

atenolol

Comparator

DRUG

lisinopril

Comparator

Trial Locations (78)

10011

GSK Investigational Site, New York

10021

GSK Investigational Site, New York

10128

GSK Investigational Site, New York

14215

GSK Investigational Site, Buffalo

14221

GSK Investigational Site, Williamsville

15212

GSK Investigational Site, Pittsburgh

17011

GSK Investigational Site, Camp Hill

18105

GSK Investigational Site, Allentown

18901

GSK Investigational Site, Doylestown

19140

GSK Investigational Site, Philadelphia

19390

GSK Investigational Site, West Grove

19718

GSK Investigational Site, Newark

20037

GSK Investigational Site, Washington D.C.

20422

GSK Investigational Site, Washington D.C.

21044

GSK Investigational Site, Columbia

21215

GSK Investigational Site, Pikesville

21224

GSK Investigational Site, Baltimore

22151

GSK Investigational Site, Springfield

24014

GSK Investigational Site, Roanoke

24541

GSK Investigational Site, Danville

27157

GSK Investigational Site, Winston-Salem

27401

GSK Investigational Site, Greensboro

28304

GSK Investigational Site, Fayetteville

29204

GSK Investigational Site, Columbia

29615

GSK Investigational Site, Greenville

29651

GSK Investigational Site, Greer

32209

GSK Investigational Site, Jacksonville

32714

GSK Investigational Site, Altamonte Springs

GSK Investigational Site, Ormond Beach

32779

GSK Investigational Site, Longwood

33029

GSK Investigational Site, Pembroke Pines

33156

GSK Investigational Site, Miami

33462

GSK Investigational Site, Atlantis

34741

GSK Investigational Site, Kissimmee

35235

GSK Investigational Site, Birmingham

35249

GSK Investigational Site, Birmingham

36608

GSK Investigational Site, Mobile

37205

GSK Investigational Site, Nashville

37660

GSK Investigational Site, Kingsport

37920

GSK Investigational Site, Knoxville

44122

GSK Investigational Site, Cleveland

45224

GSK Investigational Site, Cincinnati

45267

GSK Investigational Site, Cincinnati

46202

GSK Investigational Site, Indianapolis

46804

GSK Investigational Site, Fort Wayne

49525

GSK Investigational Site, Grand Rapids

53215

GSK Investigational Site, Milwaukee

55417

GSK Investigational Site, Minneapolis

55435

GSK Investigational Site, Edina

60061

GSK Investigational Site, Vernon Hills

60201

GSK Investigational Site, Evanston

77030

GSK Investigational Site, Chandler

GSK Investigational Site, Houston

80204

GSK Investigational Site, Denver

80218

GSK Investigational Site, Denver

80907

GSK Investigational Site, Colorado Springs

80919

GSK Investigational Site, Colorado Springs

85206

GSK Investigational Site, Mesa

85251

GSK Investigational Site, Scottsdale

85260

GSK Investigational Site, Scottsdale

85351

GSK Investigational Site, Sun City

90033

GSK Investigational Site, Los Angeles

90048

GSK Investigational Site, Los Angeles

90095

GSK Investigational Site, Los Angeles

92064

GSK Investigational Site, Poway

92120

GSK Investigational Site, San Diego

92705

GSK Investigational Site, Santa Ana

93720

GSK Investigational Site, Fresno

94301

GSK Investigational Site, Palo Alto

94578

GSK Investigational Site, San Leandro

95819

GSK Investigational Site, Sacremento

97210

GSK Investigational Site, Portland

98405

GSK Investigational Site, Tacoma

85381 - 4828

GSK Investigational Site, Peoria

04074

GSK Investigational Site, Scarborough

08103

GSK Investigational Site, Camden

97123-4117

GSK Investigational Site, Hillsboro

02886

GSK Investigational Site, Warwick

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY